Biogen | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 1.66B 3.15B 2025-03
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
ALKERMES USD 104.84M 79.35M 2025-06
Amgen USD 1.57B 405M 2025-06
Bayer EUR -426000000 2.26B 2025-06
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Gilead Sciences USD 2.43B 780M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Pfizer USD 3.04B 259M 2025-06
PTC Therapeutics USD -71052000 1B 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Sanofi EUR 1.42B 734M 2025-06
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 153.64M 537.16M 2025-06
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
United Therapeutics USD 408.4M 15.1M 2025-06
Vertex Pharmaceuticals USD 1.28B 552.6M 2025-06


Biogen Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.